Search
Descriptor English: Testolactone
Descriptor Spanish: Testolactona
Descriptor testolactona
Scope note: Antineoplásico derivado de la progesterona que se utiliza en el tratamiento del cáncer de mama avanzado.
Descriptor Portuguese: Testolactona
Descriptor French: Testolactone
Entry term(s): 1 Dehydrotestolactone
1-Dehydrotestolactone
Teslac
delta(1)-Testolactone
Tree number(s): D04.210.500.054.079.129.782
D04.210.500.496.699
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D013738
Scope note: An antineoplastic agent that is a derivative of progesterone and used to treat advanced breast cancer.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antineoplastic Agents, Hormonal
Registry Number: 6J9BLA949Q
CAS Type 1 Name: D-Homo-17a-oxaandrosta-1,4-diene-3,17-dione
Public MeSH Note: 73
History Note: 73(64)
DeCS ID: 14117
Unique ID: D013738
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1973/01/01
Date of Entry: 1999/01/01
Revision Date: 2017/05/24
Testolactone - Preferred
Concept UI M0021194
Scope note An antineoplastic agent that is a derivative of progesterone and used to treat advanced breast cancer.
Preferred term Testolactone
Entry term(s) 1 Dehydrotestolactone
1-Dehydrotestolactone
delta(1)-Testolactone
Teslac - Narrower
Concept UI M0351083
Preferred term Teslac



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey